|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0009015,
umls-concept:C0016904,
umls-concept:C0025646,
umls-concept:C0028778,
umls-concept:C0034693,
umls-concept:C0034721,
umls-concept:C0035298,
umls-concept:C0071048,
umls-concept:C0332307,
umls-concept:C0439799,
umls-concept:C0597357,
umls-concept:C1511545,
umls-concept:C1709915,
umls-concept:C1711351
|
|
pubmed:issue |
25
|
|
pubmed:dateCreated |
1996-1-24
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Ionotropic receptors for gamma-aminobutyric acid (GABA) are important to inhibitory neurotransmission in the mammalian retina, mediating GABAA and GABAC responses. In many species, these responses are blocked by the convulsant picrotoxinin (PTX), although the mechanism of block is not fully understood. In contrast, GABAC responses in the rat retina are extremely resistant to PTX. We hypothesized that this difference could be explained by molecular characterization of the receptors underlying the GABAC response. Here we report the cloning of two rat GABA receptor subunits, designated r rho 1 and r rho 2 after their previously identified human homologues. When coexpressed in Xenopus oocytes, r rho 1/r rho 2 heteromeric receptors mimicked PTX-resistant GABAC responses of the rat retina. PTX resistance is apparently conferred in native heteromeric receptors by r rho 2 subunits since homomeric r rho 1 receptors were sensitive to PTX; r rho 2 subunits alone were unable to form functional homomeric receptors. Site-directed mutagenesis confirmed that a single amino acid residue in the second membrane-spanning region (a methionine in r rho 2 in place of a threonine in r rho 1) is the predominant determinant of PTX resistance in the rat receptor. This study reveals not only the molecular mechanism underlying PTX blockade of GABA receptors but also the heteromeric nature of native receptors in the rat retina that underlie the PTX-resistant GABAC response.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/8524843-1314944,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8524843-1315307,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8524843-1317428,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8524843-1370654,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8524843-1376167,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8524843-1709741,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8524843-1847747,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8524843-1849271,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8524843-2456501,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8524843-2826149,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8524843-6259535,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8524843-7509862,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8524843-7516126,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8524843-7524561,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8524843-7678450,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8524843-7691812,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8524843-7722621,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8524843-7869263,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8524843-7965056,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8524843-8027780,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8524843-8120620,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8524843-8182433,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8524843-8229811,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8524843-8274276,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8524843-8389005,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8524843-8421521
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0027-8424
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
5
|
|
pubmed:volume |
92
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
11756-60
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:8524843-Amino Acid Sequence,
pubmed-meshheading:8524843-Animals,
pubmed-meshheading:8524843-Base Sequence,
pubmed-meshheading:8524843-Chloride Channels,
pubmed-meshheading:8524843-Cloning, Molecular,
pubmed-meshheading:8524843-Dose-Response Relationship, Drug,
pubmed-meshheading:8524843-Drug Resistance,
pubmed-meshheading:8524843-Electric Conductivity,
pubmed-meshheading:8524843-GABA Antagonists,
pubmed-meshheading:8524843-Ion Channels,
pubmed-meshheading:8524843-Methionine,
pubmed-meshheading:8524843-Molecular Sequence Data,
pubmed-meshheading:8524843-Mutagenesis, Site-Directed,
pubmed-meshheading:8524843-Picrotoxin,
pubmed-meshheading:8524843-Protein Conformation,
pubmed-meshheading:8524843-Rats,
pubmed-meshheading:8524843-Receptors, GABA,
pubmed-meshheading:8524843-Retina,
pubmed-meshheading:8524843-Sequence Homology, Amino Acid,
pubmed-meshheading:8524843-Structure-Activity Relationship
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Cloning of a gamma-aminobutyric acid type C receptor subunit in rat retina with a methionine residue critical for picrotoxinin channel block.
|
|
pubmed:affiliation |
Laboratory of Cellular and Molecular Neuroscience, Children's Hospital, Boston, MA 02115, USA.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
